Category:

Pfizer Strategist Andrew Baum Shifts to Senior Advisor Role Under Bourla

Pfizer Chief Strategy and Innovation Officer Andrew Baum is stepping down from his executive position to serve as a senior strategic advisor to CEO Albert Bourla. Baum, a former top-tier equity research analyst, joined the pharmaceutical giant in 2024 to provide an outside-in perspective on the company’s portfolio. He will support the executive team through the end of the year before departing the company entirely. Analysts view the move as part of a broader “operational simplification” as the New York-based drugmaker streamlines its leadership structure following a period of massive post-pandemic realignment…

Posted On :
Category:

LinkedIn Appoints Longtime Executive Dan Shapero as Chief Executive Officer

Microsoft has promoted Dan Shapero to Chief Executive Officer of LinkedIn, elevating a veteran leader who has been instrumental in the platform’s growth since 2008. Shapero previously served as chief operating officer and has held senior roles across product, sales, and marketing, providing him with a comprehensive view of the network’s $19 billion revenue engine. In his new capacity, he will lead the executive team and report to Ryan Roslansky, who now serves as Executive Vice President of both LinkedIn and Microsoft Office…

Posted On :
Category:

John Ternus Inherits Apple as Cook Era Comes to a Close

Apple is initiating its most significant leadership transition in over a decade as John Ternus prepares to take the helm as CEO on September 1, 2026. Tim Cook, who has served as the architect of Apple’s $4 trillion valuation, will move into the role of Executive Chairman. This upcoming transition marks the end of an era defined by Cook’s expansion into services and wearables, which transformed the company from a hardware-centric business into a diversified global powerhouse. Cook will remain active in the new structure, focusing on high-level board governance and international policy engagement…

Posted On :
Category:

Charlie Health Appoints Ashok Balakrishnan as Chief Technology Officer

Charlie Health, the nation’s largest provider of virtual high-acuity behavioral healthcare, has named Ashok Balakrishnan as its Chief Technology Officer. Balakrishnan joins the firm during a period of rapid expansion for its virtual Intensive Outpatient Programs (IOP), which provide evidence-based treatment for youth and adults facing severe mental health challenges and substance use disorders. Reporting directly to CEO and Co-Founder Carter Barnhart, Balakrishnan is tasked with scaling the company’s technical infrastructure to meet surging demand from payers and health systems…

Posted On :
Category:

6sense Strengthens Executive Team with Key Leadership Appointments

6sense has announced two major leadership appointments to support its next phase of AI-driven growth. Ashley Jefferson joins the firm as Chief People Officer, bringing over 25 years of HR leadership from companies including Synoptek and Rackspace Technology. Jefferson’s mandate is to scale the company’s global talent strategy, focusing on performance systems and “AI readiness” for the 6sense workforce…

Posted On :
Category:

SailPoint Strengthens Executive Team with The Appointment of Levent Besik as New CPO

SailPoint has appointed Levent Besik as Chief Product Officer. Besik joins the Austin-based identity security leader following a tenure as vice president of product management at Microsoft, where he led the platform strategy for both human and non-human identities. With a career pedigree that includes executive product roles at Okta and Google—where he oversaw Customer Identity and Cloud AI platforms respectively—Besik brings a specialized blend of cloud-scale AI and security expertise to SailPoint…

Posted On :
Category:

Anthropic Appoints Novartis CEO Vas Narasimhan to Board of Directors

Anthropic has announced that the Anthropic Long-Term Benefit Trust has appointed Dr. Vas Narasimhan, CEO of Novartis, to Anthropic’s Board of Directors. As a physician-scientist leading a major innovative medicines company, Narasimhan brings extensive experience in navigating highly regulated industries and overseeing the approval of over 35 novel medicines…

Posted On :